Trial intelligence / Profile preview

DPD biomarkers and 5-fluorouracil pharmacokinetics in colorectal or pancreatic cancer

NL-OMON48600Active, not recruiting

Sponsor
Catharina Ziekenhuis
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of fluorouracil in colorectal cancer (CRC) and pancreatic cancer (PC), sponsored by Catharina Ziekenhuis. Started Jul 2019; status: active, not recruiting.

02

Drugs

fluorouracil
03

Conditions

colorectal cancer (CRC)pancreatic cancer (PC)

Beyond the preview

Go deeper on NL-OMON48600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON48600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call